Peptide Blog

Sermorelin and Ipamorelin are synthetic peptides extensively studied for their potential influence on growth hormone regulation. Sermorelin is a 29-amino acid peptide fragment derived from the endogenous growth hormone-releasing hormone (GHRH), which appears to represent the biologically active N-terminal portion known as Growth Hormone Releasing Factor (1-29) or GRF (1-29). This truncation from the native...

Tripeptide-1, commonly referred to as GHK (glycyl-L-histidyl-L-lysine), is a naturally occurring oligopeptide composed of three amino acids arranged in the specific sequence glycine-histidine-lysine. Initially identified in plasma, it has since been recorded as present in a variety of physiological fluids and tissues, including cerebrospinal fluid, liver parenchyma, and platelet-derived matrices. The peptide structure is hypothesized...

Chonluten (T-34), also referred to as EDG tripeptide, is a synthetic short peptide composed of glycine, glutamine, and asparagine. Classified by researchers as a peptide bioregulator, Chonluten has been studied for its organ-specific implications, particularly in pulmonary tissue. Preliminary research has suggested that it may play a role in modulating gene expression pathways associated with...

Frag 176-191 (Fragment 176-191), which, in scientific literature, is often also referred to as hGH Fragment 176-191, tyr-hGH 177-191, or AOD 9604, is a synthetic peptide derived from the C-terminal region of the human growth hormone (hGH) molecule. This segment comprises the final 16 amino acid residues of the endogenous hGH polypeptide chain. This sequence...

Thymosin beta-4 fragments (Tβ4) is a 43-amino acid peptide first isolated from calf thymus and classified as a major G-actin-sequestering molecule within eukaryotic cells. It belongs to the β-thymosin family. Researchers believe this class of peptide may contribute to the regulation of cytoskeletal dynamics, cell migration, and tissue remodeling. Due to its ubiquitous expression and...

ACE-031 peptide, also referred to as Ramatercept, is recognized by researchers as a recombinant protein engineered by fusing the extracellular component of activin receptor type IIB (ActRIIB) with the Fc region of IgG1. This design is suggested to support the protein’s theoretical function as a decoy receptor with high affinity for several ligands in the...

Kisspeptin-10 (also referred to as “KP-10”) is a short bioactive peptide fragment of the kisspeptin family, originating from proteolytic processing of a 145-amino acid precursor encoded by the KISS1 gene. This gene product is believed to undergo sequential cleavage, yielding several functional fragments, including kisspeptin-54, kisspeptin-14, kisspeptin-13, and the decapeptide Kp-10. Among these, Kp-10 corresponds...

Recent investigations into growth hormone secretagogues (GHSs), growth hormone-releasing peptides (GHRPs), and analogs of growth hormone (hGH) have pointed to their potential in modulating endogenous hormone regulation. Individually and in combination, these agents may potentially influence physiological processes such as lipid mobilization, muscle composition, circadian rhythm modulation, and various systemic functions, including gastrointestinal and cardiovascular...

Follistatin-344 (FST-344) is an endogenous glycoprotein widely distributed across various tissues. It is classified as an autocrine signaling molecule, meaning that scientists consider it to be synthesized and secreted by cells to bind to their own surface receptors, leading to intracellular modifications. Research suggests that Follistatin exists primarily in two isoforms, FST-317 and FST-344, with...